Wenhai Yu

机构：Kunming Institute of Zoology, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Medical Biology · ORCID：0000-0002-3205-2062

发表论文 54 篇 · 总被引 3820 次 · h-index 20

代表论文

• Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target (2023 · Science Advances · 被引 48)
• Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials (2024 · Nature Communications · 被引 16)
• Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants (2024 · Signal Transduction and Targeted Therapy · 被引 15)
• CHIKV mRNA vaccines encoding conserved structural/envelope proteins confer broad cross-lineage protection against infection (2025 · Signal Transduction and Targeted Therapy · 被引 14)
• Multiorgan proteomic analysis of infected animal models predict potential host factors for chikungunya virus (2025 · MedComm · 被引 10)
• A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2 (2024 · Signal Transduction and Targeted Therapy · 被引 10)